4887 — SAWAI group Share News
0.000.00%
HealthcareConservativeMicro Cap
Brief: R&I removes Sawai Pharmaceutical from rating monitor and affirms its rating at "A-"-R&I
Refile: TABLE-Sawai Pharmaceutical - 9-MTH group results
Table: Sawai Pharmaceutical - 9-MTH group results
Table: Sawai Pharmaceutical -2017/18 group forecast(IFRS)
Brief: Sawai Pharmaceutical completes sale of 20 pct stake in Upsher-Smith Laboratories
Brief: SAWAI PHARMACEUTICAL says details of shares private placement
Brief: Sawai Pharmaceutical says share prices
Brief: Sawai Pharmaceutical to issue new shares and to distribute treasury common stock
Refile: TABLE-Sawai Pharmaceutical - 6-MTH group results
Brief: Sawai Pharmaceutical to sell 20 pct stake in SAWAI AMERICA for $211 mln
Table: Sawai Pharmaceutical - 6-MTH group results
Brief: Upsher-Smith says parent co to manufacture migraine medication in Japan With AstraZeneca
Refile: TABLE-Sawai Pharmaceutical -Q1 group results
Table: Sawai Pharmaceutical -Q1 group results
Brief: R&I places Sawai Pharmaceutical on rating monitor with view to downgrading-R&I
Japan's Sawai buys U.S. firm Upsher-Smith's generic drugs unit for $1.1 bln (updated)
Japan's Sawai Pharmaceutical to buy U.S.'s Upsher-Smith Laboratories for $1.05 bln
Brief: Sawai Pharma to buy Upsher-Smith Laboratories for $1.05 bln
Table: Sawai Pharmaceutical -9-MTH group results